The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
L | Antineoplastic and immunomodulating agents | |
2
|
L01 | Antineoplastic agents | |
3
|
L01F | Monoclonal antibodies and antibody drug conjugates | |
4
|
L01FF | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors | |
5
|
L01FF13 |
| Active Ingredient |
|---|
|
Toripalimab is a recombinant humanized programmed cell death protein 1 (PD-1) monoclonal antibody that acts as a checkpoint inhibitor. Toripalimab is used for the treatment of melanoma and nasopharyngeal carcinoma. |
| Document | Type | Information Source | |
|---|---|---|---|
| LOQTORZI Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |